Beyond ENO1, emerging roles and targeting strategies of other enolases in cancers
J. M. Ni(Chinese Academy of Sciences), Jieer Ying(Chinese Academy of Medical Sciences & Peking Union Medical College), Yihui Huang(Wuhan University), Chaoqun Li(Jiangnan University), Qian Yin(Dongguan University of Technology)
Cited by 21
Related Papers
Hepatogastroenterology
|Hepatogastroenterology|2012|1.3k
Donafenib Versus Sorafenib in First-Line Treatment of Unresectable or Metastatic Hepatocellular Carcinoma: A Randomized, Open-Label, Parallel-Controlled Phase II-III Trial
|Journal of Clinical Oncology|2021|417
The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2023
|癌症：英文版|2023|412